Clinical Trial Update: First in Human Study of TORL-1-23 in Participants With Advanced Cancer [Phase 1]

View source ↗

Summary

TORL Biotherapeutics announced a first-in-human Phase 1 trial of TORL-1-23 for advanced cancers. The study is currently recruiting and includes ovarian cancer, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• TORL-1-23

Snippet

Sponsor: TORL Biotherapeutics, LLC | Conditions: Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Status: RECRUITING